Recommended Topic Related To:

Darvocet-N

"Young children have died or become seriously ill from accidental exposure to a skin patch containing fentanyl, a powerful pain reliever. As a result of this, the Food and Drug Administration (FDA) is issuing a Drug Safety Communication to warn pa"...

Darvocet-N

Discontinued Warning IconPlease Note: This Brand Name drug is no longer available in the US.
(Generic versions may still be available.)

Indications
Dosage
How Supplied

INDICATIONS

Darvocet-N (propoxyphene napsylate and acetaminophen) is indicated for the relief of mild to moderate pain.

DOSAGE AND ADMINISTRATION

Darvocet-N (propoxyphene napsylate and acetaminophen) is intended for the management of mild to moderate pain. The dose should be individually adjusted according to severity of pain, patient response and patient size.

Darvocet-N (propoxyphene napsylate and acetaminophen) 100 (100 mg propoxyphene napsylate and 650 mg acetaminophen)

The usual dosage is one tablet every 4 hours orally as needed for pain. The maximum dose of DARVOCET-N (propoxyphene napsylate and acetaminophen) 100 is 6 tablets per day. Do not exceed the maximum daily dose.

Darvocet-N (propoxyphene napsylate and acetaminophen) 50 (50 mg propoxyphene napsylate and 325 mg acetaminophen)

The usual dosage is two tablets every 4 hours orally as needed for pain. The maximum dose of DARVOCET-N (propoxyphene napsylate and acetaminophen) 50 is 12 tablets per day. Do not exceed the maximum daily dose.

Patients receiving propoxyphene and any CYP3A4 inhibitor should be carefully monitored for an extended period of time and dosage adjustments should be made if warranted.

Consideration should be given to a reduced total daily dosage in elderly patients and in patients with hepatic or renal impairment.

Cessation of Therapy

For patients who used Darvocet-N (propoxyphene napsylate and acetaminophen) on a regular basis for a period of time, when therapy with Darvocet-N (propoxyphene napsylate and acetaminophen) is no longer needed for the treatment of their pain, it may be useful to gradually discontinue the Darvocet-N (propoxyphene napsylate and acetaminophen) over time to prevent the development of an opioid abstinence syndrome (narcotic withdrawal). In general, therapy can be decreased by 25% to 50% per day with careful monitoring for signs and symptoms of withdrawal (see Drug Abuse And Dependence for description of the signs and symptoms of withdrawal). If the patient develops these signs or symptoms, the dose should be raised to the previous level and titrated down more slowly, either by increasing the interval between decreases, decreasing the amount of change in dose, or both.

HOW SUPPLIED

Darvocet-N (propoxyphene napsylate and acetaminophen) Tablets are available in:

The 50 mg tablets are dark orange, capsule shaped, film-coated and imprinted with the script "DARVOCET-N (propoxyphene napsylate and acetaminophen) 50" on one side of the tablet, using edible black ink. They are available as follows:

Bottles of 100.........................NDC 66479-514-10

The 100 mg tablets are dark orange, capsule shaped, film-coated, and imprinted with the script "DARVOCET-N (propoxyphene napsylate and acetaminophen) 100" on one side of the tablet, using edible black ink. They are available as follows:

Bottles of 100.........................NDC 66479-515-10
Bottles of 500.........................NDC 66479-515-50

Store at 25°C (77°F); excursions are permitted to 15°- 30°C (59°- 86°F) [see USP Controlled Room Temperature].

Inform patients of the availability of a Medication Guide for Darvocet-N (propoxyphene napsylate and acetaminophen) that accompanies each prescription dispensed. Instruct patients to read the Darvocet-N (propoxyphene napsylate and acetaminophen) Medication Guide prior to using Darvocet-N (propoxyphene napsylate and acetaminophen) .

Marketed by: Xanodyne pharmaceuticals, inc. Newport, KY 41071. REV. 09/2009

Last reviewed on RxList: 12/20/2010
This monograph has been modified to include the generic and brand name in many instances.

Indications
Dosage
How Supplied
A A A

Darvocet-N - User Reviews

Darvocet-N User Reviews

Now you can gain knowledge and insight about a drug treatment with Patient Discussions.

Here is a collection of user reviews for the medication Darvocet-N sorted by most helpful. Patient Discussions FAQs

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


Chronic Pain/Back Pain

Find tips and advances in treatment.


NIH talks about Ebola on WebMD